Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1997 1
1998 5
1999 2
2000 1
2001 4
2002 3
2004 1
2006 1
2009 5
2010 1
2011 3
2012 5
2013 2
2014 3
2015 2
2016 4
2017 1
2018 3
2019 2
2020 3
2021 5
2022 1
2023 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
CD5 as a Target for Immune-Based Therapies.
Consuegra-Fernández M, Aranda F, Simões I, Orta M, Sarukhan A, Lozano F. Consuegra-Fernández M, et al. Among authors: sarukhan a. Crit Rev Immunol. 2015;35(2):85-115. doi: 10.1615/critrevimmunol.2015013532. Crit Rev Immunol. 2015. PMID: 26351145 Review.
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition.
Lledó GM, Sellares J, Brotons C, Sans M, Antón JD, Blanco J, Bassat Q, Sarukhan A, Miró JM, de Sanjosé S; Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC). Lledó GM, et al. Among authors: sarukhan a. Clin Microbiol Infect. 2022 Mar;28(3):315-318. doi: 10.1016/j.cmi.2021.11.015. Epub 2021 Nov 24. Clin Microbiol Infect. 2022. PMID: 34826619 Free PMC article. No abstract available.
Resilience after a nuclear accident: readiness in using mobile phone applications to measure radiation and health indicators in various groups (SHAMISEN SINGS project).
Liutsko L, Oughton D, Tomkiv Y, Fattibene P, Monaca SD, Nuccetelli C, Goto A, Ohba T, Lyamzina Y, Tanigawa K, Novikava N, Chumak V, Pirard P, Charron S, Laurier D, Croüail P, Schneider T, Barquinero JF, Sarukhan A, Cardis E. Liutsko L, et al. Among authors: sarukhan a. J Radiol Prot. 2023 Dec 8;43(4). doi: 10.1088/1361-6498/ad115a. J Radiol Prot. 2023. PMID: 38035396
GAD, a single autoantigen for diabetes.
von Boehmer H, Sarukhan A. von Boehmer H, et al. Among authors: sarukhan a. Science. 1999 May 14;284(5417):1135, 1137. doi: 10.1126/science.284.5417.1135. Science. 1999. PMID: 10366347 No abstract available.
Mesenchymal stem cells: myths and reality.
Sarukhan A, Zanotti L, Viola A. Sarukhan A, et al. Swiss Med Wkly. 2015 Dec 23;145:w14229. doi: 10.4414/smw.2015.14229. eCollection 2015. Swiss Med Wkly. 2015. PMID: 26700966 Free article. Review.
The pros and cons of chemokines in tumor immunology.
Viola A, Sarukhan A, Bronte V, Molon B. Viola A, et al. Among authors: sarukhan a. Trends Immunol. 2012 Oct;33(10):496-504. doi: 10.1016/j.it.2012.05.007. Epub 2012 Jun 20. Trends Immunol. 2012. PMID: 22726608 Review.
56 results